You are here

A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Chuo-ku Fukuoka, Fukuoka, Japan
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Smoking
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
20-75 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Japanese smokers motivated to quit smoking

- No period without smoking of more than 3 months

- Smoked an average of at least 10 cigarettes/day in the past year

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects who have used nicotine replacement therapy within 1 month of the study
screening visit

- Subjects intending to use nicotine replacement therapy or other smoking cessation
treatments during the study

NCT00635401
Pfizer
Completed
A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now